Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Clear Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03775850
What this trial is testing

EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

Who this might be right for
Colorectal Cancer MetastaticTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more
Evelo Biosciences, Inc. 69
Post-approval studies (Phase 4)Study completedNCT02596035
What this trial is testing

An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 197
Testing effectiveness (Phase 2)Study completedNCT03428217
What this trial is testing

CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Calithera Biosciences, Inc 444
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Not applicableStudy completedNCT02228954
What this trial is testing

IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC)

Who this might be right for
Clear-cell Metastatic Renal Cell CarcinomaKidney Neoplasms
Radboud University Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00100906
What this trial is testing

Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute 18
Testing effectiveness (Phase 2)Study completedNCT01157091
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
City of Hope Medical Center 28
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Large-scale testing (Phase 3)Ended earlyNCT02535351
What this trial is testing

Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04626479
What this trial is testing

Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 400
Testing effectiveness (Phase 2)WithdrawnNCT05176288
What this trial is testing

Avelumab, Palbociclib and Axitinib in Advanced RCC

Who this might be right for
Advanced Clear Cell Renal Cell Carcinoma
Bradley A. McGregor, MD
Testing effectiveness (Phase 2)Active Not RecruitingNCT00715442
What this trial is testing

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT01961583
What this trial is testing

[18F]Fluciclatide PET Imaging of Pazopanib Response

Who this might be right for
Kidney Neoplasm
Asan Medical Center 12
Not applicableEnded earlyNCT02747173
What this trial is testing

Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques

Who this might be right for
Renal Cell Carcinoma
Spanish Oncology Genito-Urinary Group 4
Testing effectiveness (Phase 2)Study completedNCT01024205
What this trial is testing

Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Barts and the London School of Medicine and Dentistry 43
Not applicableLooking for participantsNCT04712305
What this trial is testing

Urine Omics Predicting IO Therapy Responses in mRCC Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
National Taiwan University Hospital 400
Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Testing effectiveness (Phase 2)Ended earlyNCT00277316
What this trial is testing

Study of XL999 in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Symphony Evolution, Inc. 11
Testing effectiveness (Phase 2)Looking for participantsNCT04974671
What this trial is testing

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell CarcinomaOligoprogressive+1 more
Yale University 30
Not applicableStudy completedNCT02627144
What this trial is testing

Bevacizumab in Metastatic Renal Cancer

Who this might be right for
Renal Cell Cancer
Hoffmann-La Roche 365
Next Page